Pharmafile Logo

Portcullis Public Affairs

Portcullis Public Affairs is a leading government and communications consultancy, with over 25 years experience offering advice to prominent companies, charities and other organisations in the UK. Health specialisms include public affairs, government relations in the UK and Europe, and crisis management. We help Government reach better decisions. Portcullis is in partnership with MAP BioPharma which helps clients navigate the detailed processes so as to achieve optimal market access in the UK, Ireland and Germany. Together, we provide a unique combination of public affairs capabilities and detailed market analyses.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

11 Haymarket, London, SW1Y 4BP, United Kingdom
+44 (0)20 7368 3100

 Latest Content from PMHub 

The silent drop-off: How disengagement shows up in everyday behaviour

Press Releases | May 5, 2026 | Mednet

In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, in what is delayed, avoided...

Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...

The Power of Partnership in Respiratory Care

In the fast-paced world of modern medicine, success is often measured by the volume of tests and the precision of data. However, as Dr. Doreen Addrizzo-Harris and Dr. Martina Flammer...

Why clinical innovation doesn’t translate into real-life outcomes

Press Releases | April 30, 2026 | Mednet

We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their lives.

Strategies to enhance the provider and patient EAP experience

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Beyond the Linear Path: Leading with Your Full Self

Listen to the full episode here. In the latest episode of the Hear From Her podcast, Giulia Ghibellini (Teva Pharmaceuticals) and Professor Amanda Kirby (Do-IT Solutions) share how their experiences...

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.